COM:MILESTONEPHARMA
Milestone Pharmaceuticals, Inc.
- Stock
locale
Canadamarket
STOCKSindustry
Biotechnology Researchwebsite
milestonepharma.comcrunchbase
milestone-pharmaceuticalslinkedin
milestone-pharmaceuticalsfounding date
Jan 01, 2005ipo date
May 09, 2019
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of...Show More